Drug
Four Factor Prothrombin Complex Concentrate
Four Factor Prothrombin Complex Concentrate: highest development phase Post-Market, developed by CSL. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| four factor prothrombin complex concentrate NCT03473132 | Post-Market | Anticoagulation |
Latest
No recent events.
Follow Four Factor Prothrombin Complex Concentrate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.